Mice Model market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a latest report published by MarketsandMarkets™. Factors like growing investments and fundings in the field of drug discovery & development and increasing healthcare expenditure by developing countries are driving the growth of mice model market. Advancements in mice model, driven by breakthroughs in genetic engineering, are revolutionizing drug development and personalizing patient treatment. This is reshaping the pharmaceutical industry, fostering a more targeted and efficient approach to drug discovery and delivery.
Based on model type & service, the mice model market is segmented into model type & service. The model type segment is further sub-segmented as inbred mice, genetically engineered mice, hybrid/congenic mice, and outbred mice. The services are further sub-segmented as breeding, cryopreservation, rederivation, quarantine, and other services. Model type segment accounted for the largest share of the global mice model market in 2023. The large share of this segment can primarily be attributed to the ability of mice models to accurately mimic human diseases and conditions, enabling researchers to study disease mechanisms and test potential treatments in a controlled environment.
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1308
Based on technology, the mice model market is segmented into CRISPR/CAS9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies. In 2023, CRISPR/CAS9 accounted for the largest share of the mice model market. The large share of this segment can be attributed to a more efficient and streamlined approach to gene editing compared to traditional methods. It allows for rapid generation of genetically modified mice, reducing the time and resources required for breeding and phenotyping studies. Additionally, increased availability of funds, investments, and grants, are anticipated to propel the market for CRISPR/CAS9 technology in the forecast period.
Based on therapeutic area, the mice model market is segmented into oncology, neurology, metabolic diseases, immunology, cardiovascular diseases, and other diseases. In 2023, oncology accounted for largest share of the mice model market due to the increasing prevalence of cancer which is increasing the fundings for cancer research. Moreover, growing cancer research activities are expected to drive the demand of the segment during the forecast period.
Based on application, the mice model market has been segmented into drug discovery & development, research application, and personalized medicine. In 2023, drug discovery & development accounted for the largest market share owing to increasing demand for advanced drug products for the treatment of chronic and rare diseases.
Based on end user, the mice model market has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, and CROs and CDMOs. In 2023, pharmaceutical & biotechnology companies accounted for the largest share of the mice model market. The growing research activities, supported by rising fundings for research & development of novel drug therapies drives the growth of mice model market among pharmaceutical & biotechnology companies.
The key regional markets for the global mice model market are North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America accounted for the largest share of the market. The large share of this region can be attributed to the increasing research funding and government initiatives for promoting precision medicine, abundant infrastructure, and the presence of leading key players in the region. However, during the forecast period, the Asia Pacific is expected to be the fastest-growing regional market. Factors such as the increasing research activities in the field of genetic engineering and increasing research fundings, investments and collaborations by pharmaceutical and biotechnology companies for the pre-clinical research studies are projected to drive the growth of mice model market in Asia Pacific.
Buy a Mice Model Industry Report (399 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=1308
Mice Model market major players covered in the report, such as:
This report categorizes the mice model market into the following segments:
Mice Model Market, by Model Type & Service
Mice Model Market, by Technology
Mice Model Market, by Therapeutic Area
Mice Model Market, by Application
Mice Model Market, by End User
Mice Model Market, by region
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=1308
Key Market Stakeholders:
Report Objectives:
Media ContactCompany Name: MarketsandMarkets™ Research Private Ltd.Contact Person: Mr. Rohan SalgarkarEmail: Send EmailPhone: 18886006441Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445City: FloridaState: FloridaCountry: United StatesWebsite: https://www.marketsandmarkets.com/Market-Reports/mice-model-market-1308.html
